17.3 Avoiding Cross-Contamination Injection devices are intended for single-patient use only
Oral GLP-1s (Rybelsus and Beyond) Until recently, Rybelsus (manufactured by Novo Nordisk) was the only oral medication in its class with FDA approval
Red flag symptoms that necessitate urgent medical attention include: Sudden-onset severe headache ("thunderclap" presentation) call 999 or attend A&E immediately Headache accompanied by fever, neck stiffness, or photophobia (suggesting possible meningitis) attend A&E immediately Visual disturbances, weakness, numbness, or speech difficulties (potential neurological emergency) call 999 Headache following head injury Headache with confusion, altered consciousness, or seizures call 999 Persistent vomiting that prevents adequate hydration or medication absorption New headache in pregnancy or within 6 weeks after childbirth New headache in people over 50, especially with scalp tenderness, jaw pain when chewing, or visual symptoms (possible giant cell arteritis) requires same-day assessment Patients should also seek medical review if they experience symptoms suggestive of significant hypoglycaemia that does not respond to usual treatment, or if blood glucose readings are consistently below target despite dietary adjustments
While there is no direct, documented drug-drug interaction that prevents you from taking these two together, the combination requires a cautious approach
.jpg)
